Related Experiment Video
Updated: Oct 7, 2025

05:05
Generating a Murine Orthotopic Metastatic Breast Cancer Model and Performing Murine Radical Mastectomy
Published on: November 29, 2018
10.9K
Mouse Models to Study Secondary Cancer Prevention.
Le Li1, Vidhi Chandra1, Florencia McAllister1,2
1Departments of Clinical Cancer Prevention, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Methods in Molecular Biology (Clifton, N.J.)
|January 7, 2022
Summary
This study presents a novel mouse model for pancreatic cancer secondary prevention research. The model aids in early detection of tumor recurrence and metastasis, offering new avenues for therapeutic strategies.
Area of Science:
- Oncology
- Surgical Oncology
- Medical Imaging
Background:
- Secondary prevention aims to detect cancer recurrence or metastasis early.
- Current methods for studying secondary prevention in pancreatic cancer are limited.
- Developing effective models is crucial for advancing cancer treatment strategies.
Purpose of the Study:
- To establish and validate a preclinical mouse model for pancreatic cancer secondary prevention.
- To assess the utility of bioluminescence imaging and MRI in detecting tumor recurrence and metastasis.
- To provide a platform for evaluating surgical and therapeutic interventions against cancer spread.
Main Methods:
- Orthotopic implantation of pancreatic tumors in mice.
- Performance of distal pancreatectomy.
- Utilizing bioluminescence imaging and magnetic resonance imaging (MRI) for monitoring.
- Evaluating various surgical procedures, chemotherapy, and immunotherapy.
Main Results:
- The developed mouse model successfully mimics clinical scenarios of pancreatic cancer.
- Bioluminescence imaging and MRI proved effective in screening for tumor recurrence and metastasis.
- The model is safe, easily established, and suitable for research.
Conclusions:
- This mouse model is a valuable tool for studying secondary cancer prevention in pancreatic cancer.
- The model facilitates research into the impact of tumor resection and adjuvant/neoadjuvant therapies.
- It opens new perspectives for developing strategies to combat pancreatic cancer recurrence and metastasis.

